Steve Liang

Steve Liang is an accomplished medical professional with extensive experience in oncology and medical affairs. Currently serving as Head of US Medical Affairs Strategy for the Solid Tumor Portfolio at Genmab since November 2023, Steve previously held the position of Senior Director for Global Medical Affairs Oncology at Eisai from January 2022 to January 2024. Prior to this, Steve worked at Bayer Pharmaceuticals for over a decade, where roles included Global Medical Lead for Darolutamide and Country Medical Director. Steve's early career includes experience as an ENT Head-&-Neck physician and clinical reviewer at the Center for Drug Evaluation in Taiwan. Steve holds a medical degree from Taipei Medical University and a master's degree in Biostatistics and Epidemiology from Harvard T.H. Chan School of Public Health.